Results 151 to 160 of about 241,082 (329)

Emerging Strategies for Platelet‐Modified Nanoparticles in Targeted Tumor Therapy

open access: yesAdvanced NanoBiomed Research, EarlyView.
This review highlights innovative strategies using platelet‐modified nanoparticles to target tumors more precisely. By mimicking platelet functions, these biomimetic carriers improve tumor homing, enhance drug delivery, and reduce immune clearance.
Chunyu Bai   +5 more
wiley   +1 more source

The treatment of osteosarcoma of the extremities: Twenty year's experience at the istituto ortopedico rizzoli [PDF]

open access: bronze, 1981
Mario Campanacci   +5 more
openalex   +1 more source

Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

open access: yesEuropean Journal of Cancer, 2019
S. Smeland   +51 more
semanticscholar   +1 more source

Review of the anatomical basis for predicting plutonium alpha particle radiation induced osteogenic cancers

open access: yesThe Anatomical Record, EarlyView.
Abstract Plutonium was discovered and first synthesized in the early 1940's. Several isotopes of plutonium are used in nuclear technologies, 238Pu for heat generation and 239Pu for energy production and weapons. Both isotopes emit alpha particles, which pose a significant radiation hazard when incorporated into the body.
Scott C. Miller
wiley   +1 more source

Several occurrences of osteomyelitis in dinosaurs from a site in the Bauru Group, Cretaceous of Southeast Brazil

open access: yesThe Anatomical Record, EarlyView.
Abstract This study investigates the occurrence of osteomyelitis in non‐avian dinosaurs, focusing on the Ibirá locality, a site with a high incidence of this pathological condition. We analyzed six new osteopathic sauropod specimens from the Upper Cretaceous of Brazil.
Tito Aureliano   +3 more
wiley   +1 more source

Contribution of Organic Anion Transporter 3 in Delayed Elimination of Methotrexate by Concomitant Administration of Febuxostat

open access: yesBiopharmaceutics &Drug Disposition, EarlyView.
Coadministration of the xanthine oxidase inhibitor, febuxostat, delayed elimination of methotrexate, at least in part, by noncompetitive inhibition of human organic anion transporter 3‐mediated methotrexate transport at clinical concentrations. The findings of this study provide novel information on drug interactions associated with febuxostat ...
Kenji Ikemura   +3 more
wiley   +1 more source

Multiple osteosarcoma -report of a case-

open access: bronze, 1974
HK Chung, CK Hahm, G.T. Ahn
openalex   +1 more source

Home - About - Disclaimer - Privacy